Expertise in
2
conditions

Dr. Jonathan S. Katz

Internal Medicine
6041 Cadillac Ave, 
Los Angeles, CA 
Expertise in
2
conditions
6041 Cadillac Ave, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Jonathan Katz is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Katz is highly rated in 2 conditions, according to our data. His top areas of expertise are Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Cramp-Fasciculation Syndrome, and Spastic Paraplegia Type 2.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 7 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Internal Medicine
Licenses
Internal Medicine in CA
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

6041 Cadillac Ave, Los Angeles, CA 90034

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

7 Clinical Trials

Metabolic Profiling of Peripheral Blood Mononuclear Cells (PBMCs) by LC-MS in Prostate Cancer Patients
Metabolic Profiling of Peripheral Blood Mononuclear Cells (PBMCs) by LC-MS in Prostate Cancer Patients
Enrollment Status: Terminated
Publish Date: August 12, 2025
Intervention Type: Procedure, Other
A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of Fosigotifator in Subjects With Amyotrophic Lateral Sclerosis Followed by an Active Treatment Extension
A Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety, Tolerability, and Pharmacokinetics Following Multiple Doses of Fosigotifator in Subjects With Amyotrophic Lateral Sclerosis Followed by an Active Treatment Extension
Enrollment Status: Terminated
Publish Date: August 01, 2025
Intervention Type: Drug
Study Drug: ABBV-CLS-7262
Study Phase: Phase 1
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Enrollment Status: Enrolling_by_invitation
Publish Date: July 03, 2025
A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
A Phase 3 Randomized, Placebo-Controlled Trial With a Longitudinal Natural History Run-In and Open-Label Extension to Evaluate BIIB067 Initiated in Clinically Presymptomatic Adults With a Confirmed Superoxide Dismutase 1 Mutation
Enrollment Status: Active_not_recruiting
Publish Date: March 07, 2025
Intervention Type: Drug
Study Drug: BIIB067
Study Phase: Phase 3
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Evaluation of the Safety, Tolerability, Efficacy and Activity of AMX0035, a Fixed Combination of Phenylbutyrate (PB) and Tauroursodeoxycholic Acid (TUDCA), for the Treatment of ALS
Enrollment Status: Completed
Publish Date: May 16, 2024
Intervention Type: Other, Drug
Study Phase: Phase 2
Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Intermediate-size Patient Population Expanded Access Protocol: Repeated Administration of Nurown® (Autologous Mesenchymal Stem Cells Secreting Neurotrophic Factors) for the Treatment of Amyotrophic Lateral Sclerosis (ALS)
Enrollment Status: No_longer_available
Publish Date: April 23, 2024
Intervention Type: Biological
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS) and Evidence of Elevated Systemic Inflammation
Enrollment Status: Completed
Publish Date: May 07, 2018
Intervention Type: Drug
Study Phase: Phase 2
View 6 Less Clinical Trials

20 Total Publications

A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.
A Phase 1 study of GDC-0134, a dual leucine zipper kinase inhibitor, in ALS.
Journal: Annals of clinical and translational neurology
Published: December 09, 2021
Similar Doctors
Expertise in
11
conditions
Dr. Anthony M. Mills
Internal Medicine
Expertise in
11
conditions
Dr. Anthony M. Mills
Internal Medicine

Anthony Martin Mills M D A Medical Corporation

9201 W Sunset Blvd, Suite 812, 
West Hollywood, CA 
 (3.8 miles away)
310-550-1010
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Anthony Mills is a primary care provider, practicing in Internal Medicine in West Hollywood, California. Dr. Mills is highly rated in 11 conditions, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, Gonorrhea, and AIDS Dementia Complex.

Expertise in
55
conditions
Dr. Kamran Kalpari
Internal Medicine
Expertise in
55
conditions
Dr. Kamran Kalpari
Internal Medicine
8797 Beverly Blvd, Suite 315, 
West Hollywood, CA 
 (2.7 miles away)
310-659-0123
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kamran Kalpari is a primary care provider, practicing in Internal Medicine in West Hollywood, California. Dr. Kalpari is highly rated in 55 conditions, according to our data. His top areas of expertise are Long Haul COVID, Glossitis, Pernicious Anemia, Laminectomy, and Endoscopy.

Expertise in
67
conditions
Dr. Young-jik Lee
Internal Medicine
Expertise in
67
conditions
Dr. Young-jik Lee
Internal Medicine
266 S Harvard Blvd, Suite 100, 
Los Angeles, CA 
 (4.7 miles away)
Languages Spoken:
English
See accepted insurances

Young-jik Lee is a primary care provider, practicing in Internal Medicine in Los Angeles, California. Dr. Lee is highly rated in 67 conditions, according to our data. His top areas of expertise are Fecal Impaction, Tracheitis, Benign Paroxysmal Positional Vertigo, Vertebroplasty, and Bone Graft.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Katz's expertise for a condition
ConditionClose
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile